The purpose of this study is to evaluate the effect of fimasartan on pharmacokinetics, and the safety of digoxin.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
14
Digoxin (7 days), Digoxin + Fimasartan (7 days)
AUC, Cmax, Tmax, CL
Time frame: 0, 0.25, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10, 12, 15, 24 hours at 7 day and 28 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.